QuickView for Schmidt-Lanterman incisure (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
3. Wallerian degeneration slow (WldS)-mutant and wildtype mice before and after sciatic nerve injury
4. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
5. L1000 CMAP - T-cell ALL JURKAT cells treated with small molecule perturbagens

1. Impaired NDRG1 functions in Schwann cells cause demyelinating neuropathy in a dog model of Charcot-M…
2. Nodo-paranodopathy, internodopathy and cleftopathy: Target-based reclassification of Guillain-Barré-…
3. Intra-axonal calcium changes after axotomy in wild-type and slow Wallerian degeneration axons.
4. Visualization of cytoplasmic diffusion within living myelin sheaths of CNS white matter axons using …
5. Ultrastructural evaluation of the effects of cinnamon on the nervus ischiadicus in diabetic rats.

There were no clinical trials for Schmidt-Lanterman incisure